Jain Global’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$799K Buy
72,830
+59,367
+441% +$560K ﹤0.01% 1048
2026
Q1
$109K Buy
+13,463
New +$116K ﹤0.01% 1123
2025
Q4
Sell
-10,247
Closed -$90.7K 1381
2025
Q3
$90.7K Buy
+10,247
New +$73K ﹤0.01% 948
2025
Q2
Sell
-41,754
Closed -$276K 1425
2025
Q1
$276K Sell
41,754
-3,915
-9% -$30.5K ﹤0.01% 705
2024
Q4
$398K Buy
+45,669
New +$657K 0.01% 500

Other funds holding KURA

Jain Global's KURA Position: Q2 2026 in Review

Jain Global increased its Kura Oncology (KURA) stake by 441% in Q2 2026, buying an estimated $560K and bringing the position to 72,830 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Jain Global first reported a position in KURA in Q4 2024 and has held it in 5 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Jain Global held 72,830 shares of Kura Oncology worth $799K as of Q2 2026.
  • Jain Global bought 59,367 Kura Oncology shares in Q2 2026, an estimated $560K.
  • Kura Oncology made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1048 holding.
  • Jain Global first reported a position in Kura Oncology in Q4 2024 and has held it in 5 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.